← Leaderboards
David H Wang
Va North Texas Health Care System
$1,584,153
Attributed
$1,584,153
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $287.1K · FY2006–25$500K$375K$250K$125K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,584,153 · 2
VA$0 · 1
By mechanism
R01$1,410,045 · 1
F32$174,108 · 1
I01$0 · 1
Top collaborators
No co-investigators on record.
Most similar at Va North Texas Health Care System
Same institution · by research overlap
Others in their field
Top investigators on “Signal Pathway”
- David Heimbrook · Leidos Biomedical Research, Inc.$191,912,844
- Asrar B. Malik · University Of Illinois At Chicago$75,811,832
- Robert H Tukey · University Of California San Diego$50,504,865
- Meenhard Herlyn · University Of Pennsylvania$50,308,097
- Ian A Wilson · Scripps Research Institute, The$50,300,809
- Richard D Smith · Battelle Pacific Northwest Laboratories$46,192,560
Research focus
Signal PathwaySmoothened Signaling PathwaySignal TransductionPathway InteractionsEsophagusErinaceidaeMalignant Neoplasm Of EsophagusAffectMorbidity - Disease RateMolecularIncidenceClinical TrialsResponseMetaplasiaDistalLigandsCountryEsophagitisAdultInhibitor/AntagonistAmericanGastric AcidEsophagealEpithelial
Grant awards (12)
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer$0
I01 · FY2025 · VA · contact PI
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer$0
I01 · FY2024 · VA · contact PI
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer$0
I01 · FY2024 · VA · contact PI
A Phase II Trial to Evaluate the Effect of Itraconazole on Pathologic Complete Response Rates in Resectable Esophageal Cancer$0
I01 · FY2022 · VA · contact PI
Hedgehog signaling in the development of Barrett's esophagus$280,825
R01 · FY2017 · DK · contact PI
Hedgehog signaling in the development of Barrett's esophagus$280,765
R01 · FY2016 · DK · contact PI
Hedgehog signaling in the development of Barrett's esophagus$280,708
R01 · FY2015 · DK · contact PI
Hedgehog signaling in the development of Barrett's esophagus$280,651
R01 · FY2014 · DK · contact PI
Hedgehog signaling in the development of Barrett's esophagus$287,096
R01 · FY2013 · DK · contact PI
Hedgehog in Barrett's esophagus & assoc. adenocarcinoma$58,036
F32 · FY2008 · CA · contact PI
Hedgehog in Barrett's esophagus & assoc. adenocarcinoma$58,036
F32 · FY2007 · CA · contact PI
Hedgehog in Barrett's esophagus & assoc. adenocarcinoma$58,036
F32 · FY2006 · CA · contact PI